{"doc_id": "si-2024-0072-reg-1", "parent_doc_id": "si-2024-0072", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 72 of 2024", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2024, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) Regulations 2024. \n\n(2) The Principal Regulations, the Medicinal Products (Prescription and \nControl of Supply) (Amendment) Regulations 2005 (S.I. No. 510 of 2005), the \nMedicinal Products (Prescription and Control of Supply) (Amendment) \nRegulations 2007 (S.I. No. 201 of 2007), Part 4 of the Medicinal Products \n(Control of Placing on the Market) Regulations 2007 (S.I. No. 540 of 2007), \nthe Medicinal Products (Prescription and Control of Supply) (Amendment) \nRegulations 2008 (S.I. No. 512 of 2008), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) Regulations 2009 (S.I. No. 442 of 2009), \nthe Medicinal Products (Prescription and Control of Supply) (Amendment) \nRegulations 2011 (S.I. No. 525 of 2011), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) Regulations 2014 (S.I. No. 300 of 2014), \nthe Medicinal Products (Prescription and Control of Supply) (Amendment) \n(No. 2) Regulations 2014 (S.I. No. 504 of 2014), the Medicinal Products \n(Prescription and Control of Supply) (Amendment) Regulations 2015 (S.I. No. \n87 of 2015), the Medicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 2) Regulations 2015 (S.I. No. 449 of 2015), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) Regulations 2018 \n(S.I. No. 530 of 2018), Medicinal Products (Prescription and Control of \nSupply) (Amendment) Regulations 2020 (S.I. No. 98 of 2020), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 2) \nRegulations 2020 (S.I. No. 177 of 2020), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) (No. 3) Regulations 2020 (S.I. No. 204 \nof 2020), the Medicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 4) Regulations 2020 (S.I. No. 241 of 2020), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 5) \nRegulations 2020 (S.I. No. 401 of 2020), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) (No. 6) Regulations 2020 (S.I. No. 614 \nof 2020), the Medicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 7) Regulations 2020 (S.I. No. 698 of 2020), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) Regulations 2021 \n(S.I. No. 2 of 2021), the Medicinal Products (Prescription and Control of \nSupply) (Amendment) (No. 2) Regulations 2021 (S.I. No. 8 of 2021), the \nMedicinal Products (Prescription and Control of Supply) (Amendment) (No. 3) \nRegulations 2021 (S.I. No. 43 of 2021), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) (No. 4) Regulations 2021 (S.I. No. 81 of \nthe Medicinal Products (Prescription and Control of Supply) \n2021), \n\nNotice of the making of this Statutory Instrument was published in \n\"Iris Oifigiúil\" of 1st March, 2024. \n\n \n \n \n \n\f[72] 3 \n\n(Amendment) (No. 5) Regulations 2021 (S.I. No. 130 of 2021), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 6) \nRegulations 2021 (S.I. No. 155 of 2021), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) (No. 7) Regulations 2021 (S.I. No. 245 \nof 2021), the Medicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 8) Regulations 2021 (S.I. No. 411 of 2021), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 9) \nRegulations 2021 (S.I. No. 492 of 2021), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) (No. 10) Regulations 2021 (S.I. No. 511 \nof 2021), the Medicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 11) Regulations 2021 (S.I. No. 558 of 2021), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 12) \nRegulations 2021 (S.I. No. 578 of 2021), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) (No. 13) Regulations 2021 (S.I. No. 605 \nof 2021), the Medicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 14) Regulations 2021 (S.I. No. 692 of 2021), the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 15) \nRegulations 2021 (S.I. No. 718 of 2021), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) Regulations 2022 (S.I. No. 32 of 2022), \nthe Medicinal Products (Prescription and Control of Supply) (Amendment) \n(No. 2) Regulations 2022 (S.I. No. 57 of 2022), the Medicinal Products \n(Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2022 \n(S.I. No. 84 of 2022), the Medicinal Products (Prescription and Control of \nSupply) (Amendment) (No. 4) Regulations 2022 (S.I. No. 402 of 2022), the \nMedicinal Products (Prescription and Control of Supply) (Amendment) (No. 5) \nRegulations 2022) (S.I. No. 467 of 2022), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) Regulations 2023 (S.I. No. 11 of 2023), \nthe Medicinal Products (Prescription and Control of Supply) (Amendment) \n(No. 2) Regulations 2023 (S.I. No. 105 of 2023), the Medicinal Products \n(Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2023 \n(S.I. No. 238 of 2023), the Medicinal Products (Prescription and Control of \nSupply) (Amendment) (No. 4) Regulations 2023 (S.I. No. 284 of 2023), the \nMedicinal Products (Prescription and Control of Supply) (Amendment) (No. 5) \nRegulations 2023 (S.I. No. 422 of 2023), the Medicinal Products (Prescription \nand Control of Supply) (Amendment) (No. 6) Regulations 2023 (S.I. No. 451 \nof 2023), the Medicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 7) Regulations 2023 (S.I. No. 584 of 2023) and these \nRegulations may be cited together as the Medicinal Products (Prescription and \nControl of Supply) Regulations 2003 to 2024.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) regulation 2024 (2) principal regulation medicinal product (prescription control supply) (amendment) regulation 2005 (s.i no 510 2005) medicinal product (prescription control supply) (amendment) regulation 2007 (s.i no 201 2007) part 4 medicinal product (control placing market) regulation 2007 (s.i no 540 2007) medicinal product (prescription control supply) (amendment) regulation 2008 (s.i no 512 2008) medicinal product (prescription control supply) (amendment) regulation 2009 (s.i no 442 2009) medicinal product (prescription control supply) (amendment) regulation 2011 (s.i no 525 2011) medicinal product (prescription control supply) (amendment) regulation 2014 (s.i no 300 2014) medicinal product (prescription control supply) (amendment) (no 2) regulation 2014 (s.i no 504 2014) medicinal product (prescription control supply) (amendment) regulation 2015 (s.i no 87 2015) medicinal product (prescription control supply) (amendment) (no 2) regulation 2015 (s.i no 449 2015) medicinal product (prescription control supply) (amendment) regulation 2018 (s.i no 530 2018) medicinal product (prescription control supply) (amendment) regulation 2020 (s.i no 98 2020) medicinal product (prescription control supply) (amendment) (no 2) regulation 2020 (s.i no 177 2020) medicinal product (prescription control supply) (amendment) (no 3) regulation 2020 (s.i no 204 2020) medicinal product (prescription control supply) (amendment) (no 4) regulation 2020 (s.i no 241 2020) medicinal product (prescription control supply) (amendment) (no 5) regulation 2020 (s.i no 401 2020) medicinal product (prescription control supply) (amendment) (no 6) regulation 2020 (s.i no 614 2020) medicinal product (prescription control supply) (amendment) (no 7) regulation 2020 (s.i no 698 2020) medicinal product (prescription control supply) (amendment) regulation 2021 (s.i no 2 2021) medicinal product (prescription control supply) (amendment) (no 2) regulation 2021 (s.i no 8 2021) medicinal product (prescription control supply) (amendment) (no 3) regulation 2021 (s.i no 43 2021) medicinal product (prescription control supply) (amendment) (no 4) regulation 2021 (s.i no 81 medicinal product (prescription control supply) 2021) notice making statutory instrument published iris oifigiuil 1st march 2024 72 3 (amendment) (no 5) regulation 2021 (s.i no 130 2021) medicinal product (prescription control supply) (amendment) (no 6) regulation 2021 (s.i no 155 2021) medicinal product (prescription control supply) (amendment) (no 7) regulation 2021 (s.i no 245 2021) medicinal product (prescription control supply) (amendment) (no 8) regulation 2021 (s.i no 411 2021) medicinal product (prescription control supply) (amendment) (no 9) regulation 2021 (s.i no 492 2021) medicinal product (prescription control supply) (amendment) (no 10) regulation 2021 (s.i no 511 2021) medicinal product (prescription control supply) (amendment) (no 11) regulation 2021 (s.i no 558 2021) medicinal product (prescription control supply) (amendment) (no 12) regulation 2021 (s.i no 578 2021) medicinal product (prescription control supply) (amendment) (no 13) regulation 2021 (s.i no 605 2021) medicinal product (prescription control supply) (amendment) (no 14) regulation 2021 (s.i no 692 2021) medicinal product (prescription control supply) (amendment) (no 15) regulation 2021 (s.i no 718 2021) medicinal product (prescription control supply) (amendment) regulation 2022 (s.i no 32 2022) medicinal product (prescription control supply) (amendment) (no 2) regulation 2022 (s.i no 57 2022) medicinal product (prescription control supply) (amendment) (no 3) regulation 2022 (s.i no 84 2022) medicinal product (prescription control supply) (amendment) (no 4) regulation 2022 (s.i no 402 2022) medicinal product (prescription control supply) (amendment) (no 5) regulation 2022) (s.i no 467 2022) medicinal product (prescription control supply) (amendment) regulation 2023 (s.i no 11 2023) medicinal product (prescription control supply) (amendment) (no 2) regulation 2023 (s.i no 105 2023) medicinal product (prescription control supply) (amendment) (no 3) regulation 2023 (s.i no 238 2023) medicinal product (prescription control supply) (amendment) (no 4) regulation 2023 (s.i no 284 2023) medicinal product (prescription control supply) (amendment) (no 5) regulation 2023 (s.i no 422 2023) medicinal product (prescription control supply) (amendment) (no 6) regulation 2023 (s.i no 451 2023) medicinal product (prescription control supply) (amendment) (no 7) regulation 2023 (s.i no 584 2023) regulation may cited together medicinal product (prescription control supply) regulation 2003 2024", "start_char": 601, "end_char": 6430, "source_path": "downloads\\2024\\2024_0072.pdf", "extraction_method": "pdfminer", "checksum": "sha256:71521ad86579f00d13613056c4ade1a1e0501f5b9fad8c4f3a33681185ccb02a", "cross_refs": []}
{"doc_id": "si-2024-0072-reg-2", "parent_doc_id": "si-2024-0072", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 72 of 2024", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2024, "heading": "2. The Regulations come into operation on 1 March 2024.", "text_raw": "2. The Regulations come into operation on 1 March 2024.", "text_norm": "2 regulation come operation 1 march 2024", "start_char": 6430, "end_char": 6488, "source_path": "downloads\\2024\\2024_0072.pdf", "extraction_method": "pdfminer", "checksum": "sha256:71521ad86579f00d13613056c4ade1a1e0501f5b9fad8c4f3a33681185ccb02a", "cross_refs": []}
{"doc_id": "si-2024-0072-reg-3", "parent_doc_id": "si-2024-0072", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 72 of 2024", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2024, "heading": "In these Regulations—", "text_raw": "3. \n\nIn these Regulations— \n\n“Principal Regulations” means the Medicinal Products (Prescription and \nControl of Supply) Regulations 2003 (S.I. No. 540 of 2003); \n\n“Regulations of 2023” means the Medicinal Products (Prescription and Control \nof Supply) (Amendment) (No. 4) Regulations 2023) (S.I. No. 284 of 2023). \n\n \n \n \n\f4 [72]", "text_norm": "3 regulations-- principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) regulation 2023 mean medicinal product (prescription control supply) (amendment) (no 4) regulation 2023) (s.i no 284 2023) 4 72", "start_char": 6488, "end_char": 6820, "source_path": "downloads\\2024\\2024_0072.pdf", "extraction_method": "pdfminer", "checksum": "sha256:71521ad86579f00d13613056c4ade1a1e0501f5b9fad8c4f3a33681185ccb02a", "cross_refs": []}
{"doc_id": "si-2024-0072-reg-4", "parent_doc_id": "si-2024-0072", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 72 of 2024", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2024, "heading": "4. Regulation 8 (as amended by Regulation 7 of the Regulations of 2023)", "text_raw": "4. Regulation 8 (as amended by Regulation 7 of the Regulations of 2023) \n\nof the Principal Regulations is amended— \n\n(a) \n\nin paragraph (2)(b), by substituting “5 days’ treatment or the \nnearest equivalent minimum dosage pack unit size” for “10 \ndays’ treatment”, \n\n(b) by substituting for paragraph (4) the following: \n\n“(4) Notwithstanding the provisions of paragraphs (1)(d) and \n(2)(c), an authorised person who supplies a controlled drug \nspecified in Schedule 2, 3 or 4 to the Misuse of Drugs \nRegulations 2017 otherwise \nin accordance with a \nprescription is not guilty of an offence where, in the opinion of \nthe authorised person— \n\nthan \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\nthere is an immediate need for the medicinal \nproduct containing the controlled drug to be \nsupplied, \n\nit is safe, appropriate and necessary for the \nfor an \ncontinued \nemergency supply to be made, \n\ntreatment of \n\nthe person \n\nit is not possible to obtain a prescription without \nundue delay, \n\ntreatment with the product has, on a previous \noccasion, been prescribed for the person, \n\nno greater quantity of the product than will \nprovide 5 days’ \nthe nearest \nequivalent minimum dosage pack unit size, is \nbeing supplied, and \n\ntreatment, or \n\n(f) where the medicinal product is supplied in \naccordance with paragraph (2), the person has not \nalready been supplied with the medicinal product \nin accordance with the exemption provided in \nthat paragraph since such previous prescription.”, \nand \n\n(c) \n\nin paragraph (5), by deleting “, in the circumstances arising from \nthe Covid-19 emergency”. \n\nGIVEN under my Official Seal, \n\n29 February, 2024. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n\f[72] 5", "text_norm": "4 regulation 8 (as amended regulation 7 regulation 2023) principal regulation amended-- (a) paragraph (2)(b) substituting 5 day treatment nearest equivalent minimum dosage pack unit size 10 day treatment (b) substituting paragraph (4) following (4) notwithstanding provision paragraph (1)(d) (2)(c) authorised person supply controlled drug specified schedule 2 3 4 misuse drug regulation 2017 otherwise accordance prescription guilty offence opinion authorised person-- (a) (b) (c) (d) (e) immediate need medicinal product containing controlled drug supplied safe appropriate necessary continued emergency supply made treatment person possible obtain prescription without undue delay treatment product previous occasion prescribed person greater quantity product provide 5 day nearest equivalent minimum dosage pack unit size supplied treatment (f) medicinal product supplied accordance paragraph (2) person already supplied medicinal product accordance exemption provided paragraph since previous prescription (c) paragraph (5) deleting circumstance arising covid-19 emergency  given official seal 29 february 2024 stephen donnelly minister health 72 5", "start_char": 6820, "end_char": 8522, "source_path": "downloads\\2024\\2024_0072.pdf", "extraction_method": "pdfminer", "checksum": "sha256:71521ad86579f00d13613056c4ade1a1e0501f5b9fad8c4f3a33681185ccb02a", "cross_refs": []}
{"doc_id": "si-2024-0072-explanatory-note", "parent_doc_id": "si-2024-0072", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 72 of 2024", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2024, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to amend the provisions providing for \nexemptions for emergency supply. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) Regulations 2024. \n\n \n \n \n \n \n \n \n\f6 [72] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-520) 30. 2/24. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation amend provision providing exemption emergency supply regulation may cited medicinal product (prescription control supply) (amendment) regulation 2024 6 72 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-520) 30 2 24 propylon", "start_char": 8522, "end_char": 9486, "source_path": "downloads\\2024\\2024_0072.pdf", "extraction_method": "pdfminer", "checksum": "sha256:71521ad86579f00d13613056c4ade1a1e0501f5b9fad8c4f3a33681185ccb02a", "cross_refs": []}
